SIGA TECHNOLOGIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SIGA TECHNOLOGIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $4.26M | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $8.11M | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | $3.91M | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | $10.46M | Mar 5, 2020 |
| FY2019 | Dec 31, 2018 | $1.57M | Mar 5, 2020 |
| FY2019 | Sep 30, 2018 | $471.08M | Mar 5, 2020 |
| FY2019 | Jun 30, 2018 | $2.66M | Mar 5, 2020 |
| FY2019 | Mar 31, 2018 | $1.75M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $1.41M | Mar 6, 2019 |
| FY2018 | Sep 30, 2017 | $1.39M | Mar 6, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $94.57M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $138.72M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $139.92M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $110.78M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $133.67M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $124.96M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $26.74M | Mar 3, 2022 |
| FY2020 | Dec 31, 2018 | $477.05M | Mar 4, 2021 |
| FY2019 | Dec 31, 2017 | $12.27M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $14.99M | Mar 6, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.28M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $59.21M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $68.07M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $33.90M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $69.45M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $56.34M | Mar 2, 2023 |
| FY2019 | Dec 31, 2019 | ($4.50M) | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | ($1.21M) | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | ($3.16M) | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | $1.63M | Mar 5, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.70M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $69.98M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $83.62M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $42.70M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $89.09M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $84.50M | Mar 2, 2023 |
| FY2019 | Dec 31, 2019 | ($3.47M) | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $661.0K | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | ($1.71M) | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | $2.19M | Mar 5, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.96M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $12.31M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $16.43M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $22.53M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $9.94M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $10.94M | Mar 2, 2023 |
| FY2019 | Dec 31, 2019 | $3.92M | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $3.34M | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | $2.04M | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | $4.00M | Mar 5, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.21M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $25.14M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $22.04M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $35.12M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $18.03M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $14.72M | Mar 2, 2023 |
| FY2019 | Dec 31, 2019 | $3.50M | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $3.20M | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | $3.39M | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | $3.17M | Mar 5, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.47M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $48.76M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $94.80M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $41.61M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $11.49M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $71.52M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | ($18.20M) | Mar 3, 2022 |
| FY2020 | Dec 31, 2018 | $68.87M | Mar 4, 2021 |
| FY2019 | Dec 31, 2017 | ($18.39M) | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | ($116.81M) | Mar 6, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $29.1K | Mar 5, 2020 |
| FY2019 | Dec 31, 2018 | $102.3K | Mar 5, 2020 |
| FY2019 | Dec 31, 2017 | $100.1K | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $23.9K | Mar 6, 2019 |
| FY2017 | Dec 31, 2015 | $109.0K | Mar 6, 2018 |
| FY2016 | Dec 31, 2014 | $28.0K | Mar 7, 2017 |
| FY2015 | Dec 31, 2013 | $857.3K | Mar 4, 2016 |
| FY2014 | Dec 31, 2012 | $588.2K | Mar 6, 2015 |
| FY2013 | Dec 31, 2011 | $237.0K | Mar 10, 2014 |
| FY2012 | Dec 31, 2010 | $549.9K | May 15, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $219.47M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $244.34M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $254.35M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $195.04M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $214.73M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $149.83M | Mar 3, 2022 |
| FY2020 | Dec 31, 2019 | $198.57M | Mar 4, 2021 |
| FY2019 | Dec 31, 2018 | $203.44M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $144.67M | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $160.98M | Mar 6, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.65M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $28.53M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $57.49M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $24.88M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $40.41M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $20.04M | Mar 3, 2022 |
| FY2020 | Dec 31, 2019 | $100.78M | Mar 4, 2021 |
| FY2019 | Dec 31, 2018 | $100.53M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $467.81M | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $448.40M | Mar 6, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $198.82M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $215.80M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $196.86M | Mar 10, 2026 |
| FY2025 | Dec 31, 2022 | $170.16M | Mar 10, 2026 |
| FY2024 | Dec 31, 2021 | $174.31M | Mar 11, 2025 |
| FY2023 | Dec 31, 2020 | $129.79M | Mar 12, 2024 |
| FY2022 | Dec 31, 2019 | $97.78M | Mar 2, 2023 |
| FY2021 | Dec 31, 2018 | $102.91M | Mar 3, 2022 |
| FY2020 | Dec 31, 2017 | ($323.14M) | Mar 4, 2021 |
| FY2019 | Dec 31, 2016 | ($287.42M) | Mar 5, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $898.3K | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $898.3K | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $898.3K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $898.3K | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $898.3K | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $898.3K | Mar 3, 2022 |
| FY2020 | Dec 31, 2019 | $898.3K | Mar 4, 2021 |
| FY2019 | Dec 31, 2018 | $898.3K | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $898.3K | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $898.3K | Mar 6, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($43.07M) | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | ($22.84M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | ($38.94M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | ($63.80M) | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | ($51.76M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($95.19M) | Mar 3, 2022 |
| FY2020 | Dec 31, 2019 | ($123.03M) | Mar 4, 2021 |
| FY2019 | Dec 31, 2018 | ($115.79M) | Mar 5, 2020 |
| FY2019 | Jan 1, 2018 | $200.0K | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | ($537.38M) | Mar 6, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $154.97M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $155.40M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $150.15M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $98.79M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $103.14M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $117.89M | Mar 3, 2022 |
| FY2022 | Dec 31, 2019 | $65.25M | Mar 2, 2023 |
| FY2021 | Dec 31, 2018 | $100.65M | Mar 3, 2022 |
| FY2020 | Dec 31, 2017 | $19.86M | Mar 4, 2021 |
| FY2019 | Dec 31, 2016 | $28.70M | Mar 5, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $1.99M | Mar 6, 2015 |
| FY2013 | Dec 31, 2013 | $3.96M | Mar 10, 2014 |
| FY2012 | Dec 31, 2012 | $5.00M | May 15, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 2, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 5, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 2, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 5, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71.61M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 71.40M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | 71.09M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 72.68M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | 73.54M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | 77.20M | Mar 3, 2022 |
| FY2020 | Dec 31, 2019 | 81.27M | Mar 4, 2021 |
| FY2018 | Dec 31, 2018 | 80.76M | Mar 6, 2019 |
| FY2019 | Dec 31, 2017 | 80.76M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | 79.04M | Mar 6, 2019 |